Yong  Cheng

Physicov Med. Tech. Ltd., Zhejiangr, Zhuji, 311800, Zhejiang, China
Author    Correspondence author
Cancer Genetics and Epigenetics, 2024, Vol. 12, No. 3   
Received: 10 May, 2024    Accepted: 12 Jun., 2024    Published: 27 Jun., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The application of cancer mutation analysis in drug development offers new opportunities for personalized treatment, better meeting patient needs while reducing unnecessary treatments and potential side effects. Additionally, it revolutionizes drug development by accelerating the research and approval of new drugs. With the resolution of data management and privacy issues, the strengthening of interdisciplinary collaboration, and continuous technological advancements, cancer mutation analysis will continue to play a critical role in the future. This study aims to explore the key role of cancer mutation analysis in drug development, summarizing its methods and applications. It elaborates on genomic sequencing technologies and bioinformatics tools and databases, highlighting the importance of cancer mutation analysis in clinical applications. The goal is to promote the broad application of cancer mutation analysis, providing more effective treatment options for patients.

Cancer; Mutation analysis; Drug development; Personalized treatment; Immunotherapy